PTCT
PTC THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$61.53
+3.87%Forward multiples
Based on analyst estimates
- P/E forward
- 38.54x
- P/E 2026E
- 52.12x
- P/E 2027E
- 25.85x
- P/E 2028E
- 15.40x
- P/S forward
- 4.01x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -31.05x
- Price / sales
- 5.09x
- Price / cash flow
- -168.36x
Enterprise value
- Enterprise value
- $3.6B
- EV / sales
- 3.57x
- EV / EBITDA
- 20.76x
- EV / EBIT
- 30.99x
- Market cap
- $5.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026